Collegium Pharmaceutical's total assets for Q1 2025 were $1.63B, a decrease of -1.94% from the previous quarter. COLL total liabilities were $1.40B for the fiscal quarter, a -2.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.